Anacor and Medicis in US$160 M Acne Research Pact |
Abstract
|
Heather Cartwright |
|
Astellas Licenses Regional Rights to Optimer Pharmaceuticals’ Antibiotic for Clostridium Difficile Infection |
Abstract
|
Heather Cartwright |
|
Progenics Licenses Relistor® to Salix Outside of Japan |
Abstract
|
Heather Cartwright |
|
Novartis Advances its Capabilities in Personalised Medicine with Genoptix Acquisition |
Abstract
|
Heather Cartwright |
|
Amgen Signs Billion-Dollar Deal to Acquire BioVex for its Oncolytic Vaccine |
Abstract
|
Heather Cartwright |
|
Alexion Pharmaceuticals Boosts its Rare Disease Pipeline with Taligen Acquisition |
Abstract
|
Heather Cartwright |
|
Valeant to Acquire PharmaSwiss and Expand its Presence in Central and Eastern Europe |
Abstract
|
Heather Cartwright |
|
AdventRx Acquires SynthRx for Late-Stage Sickle Cell Disease Drug |
Abstract
|
Heather Cartwright |
|
Allergan and MAP Pharmaceuticals Sign Co-Promotion Deal for Acute Migraine Treatment |
Abstract
|
Heather Cartwright |
|
ANNUAL REVIEW: Deal Making in 2010 |
Abstract
|
Heather Cartwright |
|